LeMaitre Vascular, Inc. (LMAT)
| Previous Close | 64.03 |
| Open | 63.72 |
| Bid | 62.40 x 200 |
| Ask | 63.05 x 200 |
| Day's Range | 62.49 - 63.50 |
| 52 Week Range | 44.27 - 74.64 |
| Volume | |
| Avg. Volume | 118,667 |
| Market Cap | 1.406B |
| Beta (5Y Monthly) | 0.88 |
| PE Ratio (TTM) | 46.75 |
| EPS (TTM) | 1.34 |
| Earnings Date | May 02, 2024 |
| Forward Dividend & Yield | 0.64 (1.00%) |
| Ex-Dividend Date | Mar 13, 2024 |
| 1y Target Est | 69.13 |
GlobeNewswireLeMaitre Will Announce First Quarter 2024 Earnings Results May 2, 2024
BURLINGTON, Mass., April 19, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2024 financial results on Thursday, May 2, 2024, after the market close. The company has scheduled a conference call for 5:00 PM ET the same day to discuss the results, business highlights, and company outlook. Access to the live call is available by registering online here. All registrants will receive dial-in information and a PIN allowing them to a
ZacksAtriCure's (ATRC) cryoSPHERE+ Probe to Aid in Pain Management
AtriCure (ATRC) unveils its cryoSPHERE+ cryoablation probe, which is intended to reduce freeze times and aid in postoperative pain management.
Simply Wall St.LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat?
Most readers would already know that LeMaitre Vascular's (NASDAQ:LMAT) stock increased by 8.6% over the past three...
